Kevin R. Sayer - Jan 12, 2024 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
President, CEO and Chairman, Director
Signature
By: /s/ Jereme M Sylvain For: Kevin R Sayer
Stock symbol
DXCM
Transactions as of
Jan 12, 2024
Transactions value $
-$4,614,596
Form type
4
Date filed
1/17/2024, 06:49 PM
Previous filing
Apr 5, 2023
Next filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $72.70 +72.7K +22.2% $0.00* 400K Jan 12, 2024 Direct F1, F2
transaction DXCM Common Stock Sale -$4.61M -37.3K -9.33% $123.63 363K Jan 16, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2021 that vested on January 12, 2024.
F2 Included in this number are 115,682 unvested restricted stock units, 54,422 of which were granted on March 9, 2023 and shall vest through March 8, 2026, 43,336 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 17,924 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
F3 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.